PHAT icon

Phathom Pharmaceuticals

84 hedge funds and large institutions have $820M invested in Phathom Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

3% less capital invested

Capital invested by funds: $843M → $820M (-$23.3M)

4% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 23

Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$523K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$13.5M
2 +$8.16M
3 +$7.09M
4
JP Morgan Chase
JP Morgan Chase
New York
+$5.03M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.95M

Top Sellers

1 -$1.96M
2 -$1.6M
3 -$1.42M
4
MWNA
Marshall Wace North America
New York
-$1.17M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$2.79M
27
$2.62M
28
$2.28M
29
$2.23M
30
$2.07M
31
$1.87M
32
$1.38M
33
$1.26M
34
$1.09M
35
$1.05M
36
$995K
37
$960K
38
$857K
39
$725K
40
$724K
41
$721K
42
$640K
43
$623K
44
$560K
45
$526K
46
$479K
47
$478K
48
$478K
49
$469K
50
$438K